JPRN-UMIN000051748
Completed
未知
A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK) - A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.
Conditionsot applicable
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ot applicable
- Sponsor
- Suntory Wellness Limited
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Subjects who have regular hard exercise. (2\) Heavy drinker of alcohol and heavy smoker (3\) Subjects who use of products affecting the data of this study, such as food for specified health use, and food with function claims. (4\) Subjects who continuously take medicines. (5\) Subjects who are participating in other study or planning to participate or participated within the past 4 weeks. (6\) Subjects who are: a) heart, liver, or kidney disease (including complications of other diseases) b) undergoing treatment for or have a history of cardiovascular disease c) diabetes d) allergic to test foods e) undergoing treatment for or have a history of serious diseases such as cancer or tuberculosis f) having history of comorbidities in the gastrointestinal tract (excluding a history of cecum) (7\) Others who are judged inappropriate for participant by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study to evaluate the dose-response effect of tolvaptan 7.5mg or 15mg in HF patients who undergo cartdiac angiographyHeart FailureJPRN-UMIN000009924Showa University Northern Hospital100
Completed
Not Applicable
A study to investigate the efficacy and dose response of Euglena by questionnaires for a measure of the subjective well-beingHealthy individualsJPRN-UMIN000037200everage Brain Inc.210
Completed
Phase 4
Intranasal ketamine for moderate to severe pain in children- a dose finding study.acute painmusculoskeletal injuryAnaesthesiology - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12612000012875Southern Health60
Completed
Phase 2
The Study of Dose Response Relationship Evaluation of AryoSeven in Hemophilia PatientsCondition 1: Congenital Hemophilia A with inhibitors. Condition 2: Congenital Hemophilia B with inhibitors.Hereditary factor VIII deficiencyHereditary factor IX deficiencyIRCT20161202031193N3AryoGen Pharmed12
Completed
Not Applicable
Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patientsOveractive bladderJPRN-UMIN000012640Clinical Research Support Center Kyushu100